Grant: Discovery Grants Program - Individual
McMaster University
$25,000.00
Engineering a point-of-need diagnostic device with integrated signal transduction, sample preparation and measurement capabilities
EF 2015-16
Résumé
The first step in prevention and efficient treatment of diseases is timely and accurate diagnoses. Handheld diagnostic devices have the potential to revolutionize the healthcare industry by enabling early disease detection and patient-specific treatments at the point-of-need. The focus of the proposed system is to develop an affordable, portable, sensitive, accurate, automated and rapid platform for infectious disease diagnostics. Through a multi-disciplinary approach, an electrical microchip will be developed for parallel detection of genes contained within bacterial and viral cells. This microchip will integrate three previously separate platforms in a single microchip:
- a system for breaking down bacterial and viral cells for access to their genetic materials;
- an array of novel nanostructured microelectrodes modified with nucleic acid capture probes for selective capture of bacterial RNA or DNA;
- electronic instrumentation and measurement circuitry for sensing hybridization events.
The proposed fully-integrated biosensing device is a versatile platform with significant benefits for Canadian healthcare, pharmaceutical, food and water industries. It will:
- Significantly improve the quality of healthcare by reducing the costs of: diagnostic tests, treating hospital acquired infections, and medical treatments (through efficient and patient-specific drug selection).
- Reduce the cost of preparation of human and animal-derived pharmaceutical drugs by reducing the cost for pathogenic screening.
- Reduce the cost of water and food quality control.
- Improve safety and security of Canadians through rapid and manageable detection of biological weapons. Furthermore, the unique throughput and speed of this platform will open new possibilities for scientific research in pharmacogenomics, drug discovery, genetics, and nutrition.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
402396-2011
Name nom
Soleymani, Leyla
Department département
Engineering Physics
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2011
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
5
Nb partie
5
Application title
Engineering a point-of-need diagnostic device with integrated signal transduction, sample preparation and measurement capabilities
Keyword
NSERC
Application summary
The first step in prevention and efficient treatment of diseases is timely and accurate diagnoses. Handheld diagnostic devices have the potential to revolutionize the healthcare industry by enabling early disease detection and patient-specific treatments at the point-of-need. The focus of the proposed system is to develop an affordable, portable, sensitive, accurate, automated and rapid platform for infectious disease diagnostics. Through a multi-disciplinary approach, an electrical microchip will be developed for parallel detection of genes contained within bacterial and viral cells. This microchip will integrate three previously separate platforms in a single microchip:
- a system for breaking down bacterial and viral cells for access to their genetic materials;
- an array of novel nanostructured microelectrodes modified with nucleic acid capture probes for selective capture of bacterial RNA or DNA;
- electronic instrumentation and measurement circuitry for sensing hybridization events.
The proposed fully-integrated biosensing device is a versatile platform with significant benefits for Canadian healthcare, pharmaceutical, food and water industries. It will:
- Significantly improve the quality of healthcare by reducing the costs of: diagnostic tests, treating hospital acquired infections, and medical treatments (through efficient and patient-specific drug selection).
- Reduce the cost of preparation of human and animal-derived pharmaceutical drugs by reducing the cost for pathogenic screening.
- Reduce the cost of water and food quality control.
- Improve safety and security of Canadians through rapid and manageable detection of biological weapons. Furthermore, the unique throughput and speed of this platform will open new possibilities for scientific research in pharmacogenomics, drug discovery, genetics, and nutrition.